Search Within

Hakim Djaballah

  1. "Blood"
Formats
  1. Meeting Abstract (6)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Adult Leukemia (3)
  5. GSK Faculty (3)
  6. Hematologic Malignancies Research (3)

More Groups

People
  1. David Shum (5)
  2. Mark Frattini (4)
  3. Joseph Jurcic (3)
  4. Kristen O'dwyer (3)
  5. Mark Heaney (3)
  6. Peter Maslak (3)

More People

Years
  1. 2016 (1)
  2. 2014 (1)
  3. 2011 (1)
  4. 2009 (2)
  5. 2008 (1)
Publications
  1. Blood (6)
Publishers
  1. American Society of Hematology (6)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I trial of a pharmacodynamically-conceived decitabine and thioguanine combination in patients with advanced myeloid malignancies
    Meeting Abstract

    Rosenblat, T.; Heaney, M. L.; Jurcic, J. G.; Raza, A.; Mears, J. G.; Santos, R.; Carrillo, D.; Shum, D.; Gonzales, J.; Zikaras, K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Preclinical assessment of a novel CDC7 inhibitor: Genomewide RNAi screening identifies unique synergetic and resistance genes
    Meeting Abstract

    Liu Sullivan, N.; Bhinder, B.; Shum, D.; Ramirez, C.; Radu, C.; Djaballah, H.; Frattini, M. G.
    Blood (2011)

    Fulltext@MSK | Save
  • Discovery and validation of a novel class of small molecule inhibitors of the CDC7 kinase: Modulation of tumor cell growth in vitro and in vivo
    Meeting Abstract

    Frattini, M. G.; Shum, D.; O'Dwyer, K. M.; Brentjens, R. J.; Maslak, P.; Heaney, M.; Jurcic, J. G.; Djaballah, H.; Kelly, T. J.
    Blood (2009)

    Fulltext@MSK | Save
  • Clinical implementation of a novel high-throughput screen of primary leukemia cells to customize therapy for relapsed/refractory acute myeloid leukemia (AML)
    Meeting Abstract

    O'Dwyer, K. M.; Shum, D.; Heaney, M.; Brentjens, R. J.; Maslak, P.; Jurcic, J. G.; Djaballah, H.; Frattini, M. G.
    Blood (2009)

    Fulltext@MSK | Save
  • Small molecule inhibition of Cdc7, a key cell cycle regulator and novel therapeutic target, successfully inhibits leukemia cell growth in vitro and in vivo
    Meeting Abstract

    Frattini, M. G.; Shum, D.; O'dwyer, K. M.; Brentjens, R. J.; Yeh, R.; Maslak, P.; Heaney, M. L.; Jurcic, J.; Djaballah, H.; Kelly, T. J.
    Blood (2008)

    Fulltext@MSK | Save